Nemaura Medical
Financial ratios & Valuation

Forward Multiples (2026 – 2027)

20262027
Price/Earnings ratio
-0.00N/A
Price/Sales ratio
0.000.00
Earnings per Share (EPS)
$-0.34N/A

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-20.08K-8.92K-7.71K-7.77K-3.75K-41.43-29.30-27.20-7.35-1.57-1.59-3.75K
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/A202.78289.0053.68N/A
Price/Book Value ratio
31.48K-12.83K1.54K2.24K1.66K82.86-92.8620.36219.24-1.88-2.1682.86
Price/Cash Flow ratio
7.82K-8.21K-9.81K-10.11K-3.19K-51.81-35.34-28.38-15.71-2.63-2.58-3.19K
Price/Free Cash Flow ratio
7.88K-7.72K-9.15K-9.48K-3.12K-50.67-33.30-24.90-13.69-2.47-2.43-3.12K
Price/Earnings Growth ratio
214.32-69.91-509.07N/A-63.34-0.021.46-0.68-0.060.460.01-63.34
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A31.67%-1916.29%37.77%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A-1502.34%-12454.22%-1978.81%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A-2825.34%-18357.99%-3458.54%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A-2755.83%-18357.99%-3370.38%N/A
Effective Tax Rate
N/AN/AN/AN/AN/A-0.53%12.86%5.09%2.46%N/AN/A-0.53%
Return on Assets
-28.59%-144.54%-15.81%-20.95%-29.10%-93.47%-340.99%-17.75%-62.83%-97.11%-103.31%-93.47%
Return On Equity
-156.78%143.86%-20.05%-28.90%-44.28%-199.95%316.86%-74.88%-2979.46%119.71%239.52%-44.28%
Return on Capital Employed
-28.72%-166.88%-16.96%-23.68%-35.06%-129.20%2884.40%-15.91%-498.36%124.53%3042.06%-35.06%
Liquidity Ratios
Current Ratio
N/A6.2714.513.327.393.470.605.29N/AN/A0.823.47
Quick Ratio
218.296.2714.513.327.393.440.405.160.900.520.643.44
Cash ratio
215.942.9014.291.061.012.870.074.960.860.450.552.87
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/A73.371.94K1.14KN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/A1.57K412.323.47KN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/A1.65K2.35K3.75KN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/A144.5076.74252.75N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/A1.50K2.27K1.74KN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/A0.700.861.371.76N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/A2.9841.17-1.69-2.31N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.69N/A-0.35-6.57N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A0.740.972.431.96N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-2.28N/AN/A-1.33N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/A-0.24-0.33-0.42-0.41N/A
Company Equity Multiplier
5.48-0.991.261.371.522.13-0.924.2147.42-1.23-1.312.13
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/A-12.90-109.70-20.74N/A
Free Cash Flow / Operating Cash Flow Ratio
0.991.061.071.061.021.021.061.131.141.061.061.02
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-0.24-0.33-0.42-0.41N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-1.04-0.33-0.49-0.71N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A